39 results about "Cell recruitment" patented technology

The invention is directed to methods of inducing cell recruitment and tissue regeneration at a target site in a subject. It is also based, in part, on the discovery that a subject's own biologic resources and environmental conditions can be used for in situ tissue regeneration and thereby reduce or eliminate the need for donor cell procurement and ex vivo manipulation of such donor cells. Methods are disclosed for recruitment of a subject's own stem cells to a target region by inducing a sustained positive pressure at a target site, such as the kidney, thereby increasing the number of pluripotent cells capable of differentiating to regenerate the target tissue.

The invention relates to a human immunity improving traditional Chinese medicine preparation and a preparation method. The method includes: a, preparing culture medium mixed solution; b, sterilizing;c, cooling, d, performing inoculation to obtain fermented liquid; c, performing standing treatment to obtain the human immunity improving traditional Chinese medicine preparation. The human immunity improving traditional Chinese medicine preparation is capable of improving an in-vivo micro-ecological environment, balancing and regulating intestinal probiotics, repairing damaged cells, replenishingvarious in-vivo active bio-enzymes, amino acids, nucleic acids, trace elements and the like, improving human immunity and preventing diseases. In addition, the human immunity improving traditional Chinese medicine preparation is capable of improving acidic physique into alkalescent physique, can be used for preparing pills, ointments, aqueous solutions and the like and has a great auxiliary treatment effect in human immunity improvement.

The invention relates to COnditional Bispecific Redirected Activation constructs, or COBRAs, that are administered in an active pro-drug format. Upon exposure to tumor proteases, the constructs are cleaved and activated, such that they can bind both tumor target antigens (TTAs) as well as CD3, thus recruiting T cells expressing CD3 to the tumor, resulting in treatment. In some embodiments, the tumor target antigen is B7H3.

The invention discloses an erythrocyte gel delivery system as well as a preparation method and application thereof, and belongs to the technical field of biological materials. The preparation method comprises the following steps: uniformly mixing an active ingredient or a delivery carrier containing the active ingredient and fresh blood, and performing mild drying after preliminary coagulation toprepare the erythrocyte gel delivery system. The preparation method of the erythrocyte gel delivery system provided by the invention is simple and fast, and the erythrocyte gel delivery system has theadvantages of high drug loading, high biological safety and high biodegradability; erythrocyte gel has the effects of immune stimulation and immune cell recruitment, and can form an immune niche at an implantation site; an immunomodulator and a tumor-associated antigen contained in the erythrocyte gel vaccine prepared by the method stimulates recruited immune cells to differentiate into immune cells with tumor antigen specificity after being implanted, and induce production of highly effective anti-tumor immune responses.

The invention relates to a fiber wound repair stent loaded with phase change material particles as well as a preparation method and application of the fiber wound repair stent. According to the invention, aliphatic polyester, a natural polymer and a phase change material are used as main raw materials, antibacterial drugs, active substance particles and growth factors are added, and the multi-layer scaffold with biological activity is prepared through electrostatic spinning, electrostatic spraying and the like. Different types of antibacterial drugs are added into the fiber wound repair stent provided by the invention, so that multiple antibacterial effects are achieved; the bioactive substance particles with the deposition density gradient increased are contained, so that cell recruitment and migration are promoted; the phase-change material particles containing the repair-promoting growth factors are used for regulating and controlling behaviors of different cells through photo-thermal trigger type controllable delivery of the growth factors. The stent material provided by the invention has excellent biocompatibility and degradation performance, can mediate migration, proliferation, differentiation and paracrine effects of cells, and can accelerate the wound repair speed and improve the wound healing effect.

The invention relates to an injectable bone induction repair material and a preparation method thereof, and belongs to the technical field of biomedical materials. The preparation method specifically comprises the following steps of: S1, performing mineralization treatment on biological bones to obtain mineral substances from the biological bones, and crushing the mineral substances from the biological bones to obtain composite inorganic mineralized particles; S2, performing oscillation adsorption on active factors and the composite inorganic mineralized particles, so that the active factors are stably adsorbed on the surfaces of the composite inorganic mineralized particles through electrostatic attraction to obtain adsorbed composite inorganic mineralized particles; and S3, uniformly mixing the adsorbed composite inorganic mineralized particles with a gel aqueous solution to obtain the bone induction repair material. The bone induction repair material prepared by the preparation method is easy to shape and can be used through injection; and the bone induction repair material has ultrahigh crystallinity and crystallization purity, and pores are communicated with each other, so that cells can be combined with the active factors to promote cell recruitment.

The invention herein is related to the use of Lactobacillus reuteri strains as immune enhancing agents, methods of improving immune-function in mammals using Lactobacillus reuteri strains in products containing cells of such strains and the products as such. These strains exhibit good toxin binding and neutralizing effect, and exhibit good CD4+ cell recruitment.

Acute myeloid leukemia (AML) is a clonal disorder of hematopoietic stem and progenitor cells. It is a devastating disease with a poor prognosis and an average 5-year survival rate of about 30%. Disclosed herein are composition and methods for treating leukemia with a biomaterial comprising a polymer scaffold, a dendritic cell activating factor, a dendritic cell recruitment factor, and at least one leukemia antigen. The biomaterial-based vaccine disclosed herein promotes a potent, durable and transferable immune response against acute myeloid leukemia to prevent cell engraftment and synergizes with chemotherapy to prevent relapse.

The invention relates to the field of tissue regeneration biological material development, and discloses a gel microcapsule which carries a stroma cell-derived factor-1 alpha nanoparticles and a platelet-derived growth factor-BB nanoparticles and has a cell recruitment function and a preparation method thereof, and a gel microcapsule preparation with the cell recruitment function and a preparation method thereof. The gel microcapsule with the cell recruitment function and the preparation thereof can be applied to the dentistry to promote regeneration of endogenous periodontium by recruiting own stem cells of the organism. The gel microcapsule with the cell recruitment function is characterized by comprising the stroma cell-derived factor-1 alpha nanoparticles and the platelet-derived growth factor-BB nanoparticles, glycidyl methacrylate dextranum having the weight-average molecular weight of 100-105 kDa, gelatin having the weight-average molecular weight of 100 kDa, polypropylacrylamide having the weight-average molecular weight of 17 kDa, and a cosolvent, an emulsifier and a stabilizer.

The present invention discloses a method for isolating bioactive peptides and/or binding domains in an inactive ("off") state until binding to a second designed polypeptide, referred to as a key, only when a protein switch component is co-localized when bound to its target. The polypeptides induce protein switches that activate ("open") the conformational change of the bioactive peptide or binding domain, components of such protein switches, and uses thereof.